In my previous articles, I explained that I set up my 14 pots of gold using ChatGPT and Claude.
If all 14 pots are completed, I will be able to get 5k in passive income per month.
Here is my status as of today:

I have only completed 6 out of the 14 pots.
Building a Dividend Portfolio That Lasts Forever
My investment portfolio is built around one simple goal: generating S$5,000 a month in passive dividend income, sustainably, for the rest of my life. No capital withdrawals. No selling down assets. Just a portfolio that quietly pays me while I sleep.
To get there, I organise every holding into one of three sleeves — Ballast, Income, and Growth.
Ballast is the foundation. These are assets that hold their value when markets fall apart — long-duration government bonds, Singapore Savings Bonds, T-bill ladders, and cash. They don't generate exciting returns, but they're not supposed to. Their job is to be there when everything else isn't. In a portfolio designed to last 40 years, surviving drawdowns matters as much as capturing upside.
Income is the engine. This is where most of the portfolio lives — Singapore REITs, dividend-paying blue chips like DBS and UOB, global income ETFs like VHYD, and infrastructure trusts. These holdings are chosen for yield quality, distribution sustainability, and diversification across sectors and geographies. The target is a blended yield high enough to generate S$5,000 a month without relying on capital gains.
Growth is the kicker. A smaller sleeve of higher-conviction, lower-yield positions — S&P 500 ETFs, Nasdaq exposure, SGX — that compound quietly in the background. These don't contribute much income today, but they protect the portfolio's real value against inflation over decades. A portfolio that generates S$5,000 a month today but doesn't grow will be worth far less in purchasing power terms by 2045.
The three sleeves work together. Ballast keeps you calm in a crisis. Income pays the bills. Growth makes sure those bills stay paid in real terms.
Enjoy the journey!
Onwards!
No comments:
Post a Comment